Semuloparin sodium

Semuloparin sodium is an ultra–low molecular weight heparin (ULMWH) anticoagulant that was developed by Sanofi for prevention of venous thromboembolism but is no longer in active clinical development. The directory classifies it as a discontinued API with a biotechnology source/manufacturing origin. Other names for this substance include Visamerin and semuloparine sodique. Its PubChem SID is 481110487.

CAS No 9041-08-1
Molecular Formula N/A
Molecular Weight 2,000–3,000 g/mol
Synonyms N/A

Frequently Asked Questions